VNRX:NYSEAMERICAN
VolitionRX Ltd
$0.34
arrow_downward
-0.58%(-0.0020) 1D
$0.34
arrow_downward
-1.18% (-0.0040)todayPre-market
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VNRX...
Open
$0.35
High
$0.35
Low
$0.33
Mkt. cap
6.28M
Avg. vol.
15.70M
Volume
9.49K
52-wk high
$3.26
52-wk low
$0.13
EPS
-$3.80
Beta
1.10
Shares outstanding
18.73M
No. of employees
57
Open
$0.35
High
$0.35
Low
$0.33
Mkt. cap
6.28M
Avg. vol.
15.70M
Volume
9.49K
52-wk high
$3.26
52-wk low
$0.13
EPS
-$3.80
Beta
1.10
Shares outstanding
18.73M
No. of employees
57
News stories
From web sources and news partners
GuruFocus
·
5 hours ago
Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value
GuruFocus
·
18 hours ago
VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist
TradingView
·
20 hours ago
VNRX: Strong IP, new products, and global partnerships drive licensing and clinical adoption in 2026
Stock Titan
·
20 hours ago
A blood-based method detected 95% of stage I and II cancers.
About VolitionRX Ltd
CEOCameron Reynolds
Employees57
Founded2010
HeadquartersHenderson, Nevada, United States
SectorMedical device
Websitevolition.com